US7105169B2ExpiredUtilityA1
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
Est. expiryApr 27, 2015(expired)· nominal 20-yr term from priority
Inventors:Michael R. Boyd
A61K 38/164A61P 31/18A61P 31/12A61L 2/16A61L 2/18A61K 47/6833A61L 2/186C07K 14/195A61K 47/6817A61L 2/23A61L 2103/05
72
PatentIndex Score
2
Cited by
137
References
1
Claims
Abstract
The present invention provides, among other things, methods of removing virus from a sample, a composition comprising a solid support matrix to which is attached a cyanovirin, a conjugate comprising a cyanovirin coupled to at least one effector component, a composition comprising such a conjugate, methods of inhibiting prophylactically or therapeutically a viral infection of a host, and a matrix-anchored anti-cyanovirin antibody.
Claims
exact text as granted — not AI-modified1. A method of inhibiting a viral infection of a host, which method comprises administering to said host a composition comprising an antiviral effective amount of a conjugate comprising an isolated and purified cyanovirin protein consisting of an amino acid sequence of SEQ ID NO: 2, wherein said cyanovirin protein binds to a virus envelope glycoprotein, and wherein said cyanovirin protein is conjugated to at least one effector component selected from the group consisting of polyethylene glycol, dextran, albumin, and a toxin, whereupon administration of said antiviral effective amount of said composition, said viral infection is inhibited.
Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.